The Burrill Report

The Burrill Report
Contributor since: 2009
Company: Burrill & Company
Hyperion Therapeutics Goes Public
Merrimack IPO Falls Out Of The Gate
Big Biotech Fuels M&A Activity
5 Pharma Setbacks This Week
Teva Names A New CEO